ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 2.11 USD -3.21% Market Closed
Market Cap: 421.6m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+287%
Revenue
Forecast
+523%
Operating Income
Forecast
-6%
Net Income
Forecast
+7%

Wall Street
Price Targets

ATAI Price Targets Summary
ATAI Life Sciences NV

Wall Street analysts forecast ATAI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATAI is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 11.55 USD.

ATAI Lowest Forecast
Wall Street Target
5.05 USD
139% Upside
ATAI Average Forecast
Wall Street Target
8.16 USD
287% Upside
ATAI Highest Forecast
Wall Street Target
11.55 USD
447% Upside
Lowest
Price Target
5.05 USD
139% Upside
Average
Price Target
8.16 USD
287% Upside
Highest
Price Target
11.55 USD
447% Upside
ATAI Life Sciences NV Competitors:
Price Targets
326030
SK Biopharmaceuticals Co Ltd
55% Upside
MRK
Merck KGaA
43% Upside
Z
600267
Zhejiang Hisun Pharmaceutical Co Ltd
30% Downside
GRANULES
Granules India Ltd
26% Upside
326030
SK Biopharmaceuticals Co Ltd
55% Upside
MRK
Merck KGaA
43% Upside
Z
600267
Zhejiang Hisun Pharmaceutical Co Ltd
30% Downside
GRANULES
Granules India Ltd
26% Upside
000538
Yunnan Baiyao Group Co Ltd
24% Upside
H
13
HUTCHMED (China) Ltd
36% Upside
CRON
Cronos Group Inc
9% Downside
TERN
Terns Pharmaceuticals Inc
379% Upside

Revenue
Forecast

Revenue Estimate
ATAI Life Sciences NV

The compound annual growth rate of ATAI Life Sciences NV's revenue for the next 3 years is 539%.

N/A
Past Growth
539%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
ATAI Life Sciences NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
ATAI Life Sciences NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

See Also

Summary
ATAI intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATAI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATAI stock valuation using valuation multiples.
Wall Street Estimates
ATAI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATAI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATAI's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for ATAI is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 11.55 USD.

What is ATAI Life Sciences NV's Revenue forecast?
Projected CAGR
539%

The compound annual growth rate of ATAI Life Sciences NV's revenue for the next 3 years is 539%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.